Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Hematol Oncol Clin North Am. 2017 Apr;31(2):317–334. doi: 10.1016/j.hoc.2016.11.006

Table 7.

Immunohistochemical profile of LyP and ALCL

LyP pcALCL scALCL
Clonality 40–100% >90% ~90%
CD30 + (type B, variably) >75% + (required for diagnosis) +
CD56 ~10% 12–75% + (worst prognosis)
Bcl-2 30% +
Cytotoxic molecules: TIA-1, Granzyme B or Perforin + ~50% +
ALK Rare 50%
CLA + Variable
EMA +
t(2;5)(pq23;q35) translocation <10% 70–75%

Data from references 30, 59, and 60